Dow ends higher after UnitedHealth gains, other indexes slip on rate cut uncertainty

The Dow Jones Industrial Average gained 0.08%, hitting an intraday record, primarily driven by a nearly 12% surge in UnitedHealth Group (UNH) shares following Berkshire Hathaway's increased stake. Conversely, the S&P 500 and Nasdaq Composite declined 0.29% and 0.40% respectively, as mixed economic data, including stable retail sales but softer consumer confidence and factory output, intensified uncertainty around the Federal Reserve's potential September rate cut. Despite Wall Street indexes recording a second consecutive week of gains, concerns persist regarding market complacency and the broader economic impact of tariffs.

Analysis

The U.S. market exhibited significant divergence, with the Dow Jones Industrial Average gaining 0.08% to reach an intraday record, while the S&P 500 and Nasdaq Composite fell 0.29% and 0.40% respectively. The Dow's strength was almost entirely attributable to a nearly 12% surge in UnitedHealth Group (UNH), its largest single-day gain since March 2020, following the disclosure of an increased stake by Berkshire Hathaway. This move lifted the broader healthcare sector (.SPXHC) to its best weekly performance since October 2022 and provided a notable boost to the price-weighted index. However, broader market sentiment remains cautious due to uncertainty surrounding the Federal Reserve's monetary policy. While markets have largely priced in a September rate cut, mixed economic data—including stable retail sales but weakening consumer confidence and factory production—complicates the outlook and suggests tariffs may be impacting the economy. This sentiment was echoed in specific stock movements, with Applied Materials (AMAT) tumbling 14% on a weak forecast and Bank of America (BAC) dropping 1.6% after Berkshire Hathaway reduced its stake. Market internals reflected this underlying weakness, as declining issues outnumbered advancers and trading volume was light at 16.3 billion shares, below the 20-day average, signaling a lack of broad conviction behind the Dow's advance.

Key Decisions for Investors

• Given the market's divergence, where the Dow's gain was driven by a single stock against negative breadth on the NYSE and Nasdaq, investors should exercise caution as the rally lacks broad conviction.
• The significant positive reaction in UnitedHealth (UNH) to institutional investment suggests potential value in beaten-down large-cap names, but Berkshire's simultaneous trimming of Bank of America (BAC) advises a highly selective, stock-specific approach.
• Closely monitor upcoming Personal Consumption Expenditures (PCE) data, as it is the Fed's preferred inflation gauge and will be a critical determinant for the widely anticipated September rate cut, potentially challenging current market complacency and valuations.
• The sharp contrast between Applied Materials' 14% plunge on a weak outlook and Intel's gain on potential government support underscores significant idiosyncratic risk within the semiconductor sector, warranting a careful review of individual company fundamentals.